Patent · US Active

Protease variants and uses thereof

US12129499B2 · kind B2 · utility

0Cited by
17References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 5, 2024
Grant dateOct 29, 2024
Priority date
Expiry dateJan 5, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/50
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Embodiments provided herein, provide for polypeptides and molecules comprising a polypeptide having protease activity and a variant Fc molecule, pharmaceutical compositions comprising the same, and methods that can be used to treat disorders, such as IgG mediated disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.